when intellia therapeutics submit bla for lonvo-z
before April 2027
when intellia therapeutics submit bla for lonvo-z. Best Yes near 80¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 80¢ · Best No: 27¢ · 1 platform
- Kalshi: Yes 80¢ / No 27¢
LIVE
before April 2027
Volume
$400
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Apr 1, 2027
~290 days left
Category
Culture
Yes
80¢
Kalshi
No
27¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Apr 1, 2027, then the market resolves to Yes.
Market Details
ResolutionResolves Apr 1, 2027
Time Left290 days
Status● Active
CategoryCulture
Yes
80¢
Kalshi
Payout 1.3x
No
27¢
Kalshi
Payout 3.7x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In